incretina glp 1 GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits Incretin and Pancreatic β-Cell Function

Kalas et al (2023) : Frequency of GLP-1 receptor agonists use in diabetic patients diagnosed with delayed gastric emptying and their demographic profile In this retrospective chart review, GLP-1 RA use was associated with delayed gastric emptying in patients who had diabetes for less than 10 years

Results from the LEAN trial demonstrated that 39% of patients receiving liraglutide achieved histological resolution of NASH compared with merely 9% in the placebo group

24 Here we demonstrate that both of these obstacles are surmountable by using a 1 H-MRS editing method to measure CNS GSH levels, and a noninvasive (in)GSH administration strategy

Can I take the wolverine stack orally

Do not use GLP-1 medications if you or your family have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)